The State Food and Drug Administration (SFDA) announced that a Chinese institute has been designated to be a World Health Organization (WHO) Collaborating Center for the standardization and evaluation of biological products.
“The designation will help China become a major player in biological product standardization and evaluation and boost the country’s global competitiveness in the research and development of biotechnology,” said Wang Junzhi, director of the IBPC (Institute for Biological Product Control). In fact, the IBPC belongs to the National Institutes for Food and Drug Control (NIFDC) in China, it is the first WHO Collaborating Center for the standardization and evaluation of biological products located in an emerging country, and is the seventh in the world, according to the SFDA.
The WHO official website indicates that the work plan includes a various amount of activities that will contribute to the development of international standards for vaccines and other biological products, and also help their implementation into regulatory practice. Moreover, the initial period of designation is four years.
Source : www.xinhuanet.com – Publication date : 2013-01-17